* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
BSP:PFRM3's PEG Ratio is ranked better than 93.75% of 48
companies
in the Medical Distribution industry
Industry Median: 1.895
vs BSP:PFRM3: 0.34
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Profarma Distribuidora De Produtos Farmaceuticos PEG Ratio Related Terms
Profarma Distribuidora De Produtos Farmaceuticos PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Profarma Distribuidora De Produtos Farmaceuticos PEG Ratio Chart
Profarma Distribuidora De Produtos Farmaceuticos Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profarma Distribuidora De Produtos Farmaceuticos PEG Ratio vs Medical Distribution Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a PEG Ratio of 0.34 as of Jul. 06, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. This is 35% below median its historical median of 0.52. Over the past decade, Profarma Distribuidora De Produtos Farmaceuticos' PEG Ratio has ranged from 0.11 to 83.15. According to the industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #3 out of 48 companies in the Medical Distribution industry, placing it in the top 6.2%.
Is Profarma Distribuidora De Produtos Farmaceuticos' PEG Ratio too high?
Profarma Distribuidora De Produtos Farmaceuticos' current PEG Ratio of 0.34 is 35% below median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 83.15. The Medical Distribution industry median PEG Ratio is 1.90. Profarma Distribuidora De Produtos Farmaceuticos' value of 0.34 is 82.1% below this industry median. Based on the distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #3 out of 48 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' PEG Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Profarma Distribuidora De Produtos Farmaceuticos ranks #3 out of 48 companies for PEG Ratio. This places Profarma Distribuidora De Produtos Farmaceuticos in the top 6% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.90. Profarma Distribuidora De Produtos Farmaceuticos' value of 0.34 is 82.1% below this benchmark. Historically, Profarma Distribuidora De Produtos Farmaceuticos' own PEG Ratio has ranged from 0.11 to 83.15 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 1.90, Profarma Distribuidora De Produtos Farmaceuticos has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Distribution company?
The median PEG Ratio among Medical Distribution companies is 1.90, based on 48 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profarma Distribuidora De Produtos Farmaceuticos's current PEG Ratio of 0.34 is 82.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. For the Medical Distribution industry, the median PEG Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profarma Distribuidora De Produtos Farmaceuticos's current PEG Ratio is 0.34, which is 35% below median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.03, compared to a current price of R$6.72 — trading 16.3% below its estimated fair value. The current PEG Ratio is 0.34, which is 35% below median its 10-year median of 0.52 and 82.1% below the Medical Distribution industry median of 1.90. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current PEG Ratio is 0.34 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued.
The current stock price of R$6.72 is trading 16.3% below its estimated GF Value™ of R$8.03.
GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.
Key valuation signals for BSP:PFRM3:
PEG Ratio: 0.34 (35% below median its 10-year median of 0.52)
GF Value™: R$8.03 vs. price of R$6.72 (16.3% below fair value)
Industry Position: 82.1% below the Medical Distribution median (#3 of 48)
No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profarma Distribuidora De Produtos Farmaceuticos Business Description
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score
Get the complete analysis for BSP:PFRM3
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:PFRM3 has been successfully added to your 
